pH sensitive succinyl chitosan microparticles: A preliminary investigation towards oral insulin delivery

Trends in Biomaterials and Artificial Organs

Volumn 21, Issue 2, 2008, Pages 107-115

  Rekha, M R ^a   Sharma, Chandra P ^a  

^a SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESION; INSULIN; PEPTIDES; POLYSACCHARIDES;

BIOAVAILABILITY; MUCOADHESIVE DRUG DELIVERY SYSTEM; SUCCINYL CHITOSAN;

DRUG DELIVERY;

EID: 38049050377     PISSN: 09711198     EISSN: 09711198     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. J.F. Woodley, Enzymatic barriers for D.S. Schade, R.P. Eaton, Insulin delivery: how, when, and where, N Engl J Med. 312, 1120-1121 (1985).
2. J. Gordon Still. Development of oral insulin: progress and current status, Diabetes Metabolism and Reviews, 18, S29-S37 (2002).
3. R. Langer, How to got drugs where they need to go. Where a pill won't reach, Sci. Am., 288, 50 (2003)
4. GI peptide and protein delivery, Crit. Rev. Ther. Drug, 11, 61-95 (1994).
5. E. Mathiowitz, D. Chickering. J.S. Jacob, and C. Santos. Bioadhesive drug delivery systems, in Encyclopaedia of Controlled Drug Delivery, (Ed.) Edith Mathiowitz, John Wiley and Sons, Now York: 9-45 (1999).
6. K.A. Janes, P. Calvo and M.J. Alonso, Polysaccharide colloidal particles as delivery systems for macromolecules, Adv. Drug Delivery Rev., 47, 83-97 (2001a).
7. J. Eldridge, C. Hammond, and J. Meulbroek. Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the peyer's patches. J. Controlled Release, 11, 205-214 (1990).
8. X. Yang and J.R. Robinson. Bioadhesion in mucosal drug delivery, in Biorelated polymers and gels (Ed.) Teruo Okano, Academic Press, USA: 135-192 (1998).
9. W.R. Gomez and S.F.Wee, Protein release from alginate matrices, Adv. Drug Deliv. Rev. 31,267-285 (1998).
10. M. Prabaharan and J.F. Mano, Chitosan-based microparticles as controlled drug delivery systems. Drug Del 12, 41-57 (2005).
11. C. M. Lehr, J. A Bowstra, E. H. Schacht and H. E. Jungiger, In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers, Int. J. Pharm. 78, 43 (1992).
12. Ulker Guliyeva, Filiz Oner, Sule Ozsoy and Rifki Haziroglu Chitosan microparticles containing plasmid DNA as potential oral gene delivery system, Eur J Pharm Biopharm 62, 17-25 (2006)
13. Y. Song, H. Onishi, Y. Machida, T. Nagai Drug release and antitumor characteristics of N-succinyl chitosan-mitomycin C as an implant, J. Control. Release, 42 93-100 (1996).
14. A.M. Lowman, M. Morishita, M. Kajita, T. Nagai and N.A. Peppas, Oral delivery of insulin using pH-responsive complexation gels, J. Pharm. Sci. 88, 933 (1999).
15. R. Ymiaguchi. Y. Arai and T. Itoh, Preparation of partially succinylated chitosans and their cross-linked gels, Carb. Res. 58, 172-175 (1981).
16. T. Okuyama, K. Satake, On the preparation and properties of 2,4,6- trinitrophenyl-amino acids and peptides. J. Biochem. 47 (1960) 454-466.
17. M.P. Rekha and C.P. Sharma, Chitosan derivatives as oral insulin delivery system in Proceedings International Conference on Polymers for Advanced Technologies MACRO (2004) India.
18. L. Serra, Jose Dome'nech and N.A. Peppas, Design of poly(ethylene glycol)-tethered copolymers as novel mucoadhesive drug delivery systems, Eur J Pharm Biopharm., 63, 11-18 (2006)
19. K V. Ranga Rao and B.A. Buri, A novel in situ method to test polymers and coated microparticles for bioadhesion, Int. J. Pharm. 52, 265-270 (1989)
20. I.M. Klotz, in: Methods in Enzymology C.H.W. Hirs (Ed.), 11, 576 (1967).
21. Y. Shigemasa, H. Matsura, H. Sashiwa and H. Saimoto, Evaluation of different absorbance ratios from IR spectroscopy for analyzing the degree of deacetylation in chitin, Int. J Biol Macromol. 18, 237-242 (1996).
22. Y. Dang, C. Xu, J. Wang, H. Wang, Y. Wu and Y. Ruan, Determination of degree of substitution for N-acetylated chitosan using IR spectra, Science in China. Series B. 44, 216-224, (2001)
23. K Aiedeh and M. O. Tahab, Synthesis of Chitosan Succinate and Chitosan Phthalate and Their Evaluation as Suggested Matrices in Orally Administered, Colon-Specific Drug Delivery Systems, Arch. Pharm. Pharm. Med. Chem. 332 103-107 (1999).
24. H.L. Luessen, B.J. de Leeuw, M. W. Langemeyer, A. B. de Boer, J. C. Verhoef and H. E. Junginger, Mucoadhesive polymers in peroral peptide drug delivery. VI. Carborner and chitosan improve the intestinal absorption of the peptide drug buserelin in vivo, Pharm. Res. 13, 1668-1672 (1996).
25. D. Solomonidou, K. Cremer, M. Krumme and J. Kreuter, Effect of carborner concentration and degree of neutralization on the mucoadhesive properties of polymer films, J. Biomater. Sci. Polymer Edn. 12, 1191-1205 (2001).
26. Lamprecht and U. Schafer, C-M. Lehr, Size-Dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa, Pharm. Res. 18, 788 (2001).
27. E. Duizer, C. Van der wulp, C. H. M. Versantvoort and J. P. Groten, Absorption enhancement, structural changes in tight junctions and cytotoxicity caused by palmitoylcarnitine in Caco-2 and IEC-18 cells, J. Pharmacol. Exp. Ther., 287 395-402 (1998).
28. C-M. Lehr, J. A. Bouwstra, W. Kok, A. G. de Boer, J. J. Tukker, J. C. Verhoef, D. D. Breimer, and H. E. Junginger, Effects of the mucoadhesive polymer polycarbophil on the intestinal absorption of a peptide drug in the rat, J. Pharm. Pharmaco. 44, 402-407 (1992)
29. M. Morishita, T. Goto, N. A. Peppas, J. I. Joseph, M. C. Torjman, C. Munsick, K Nakamura, K. Takayama, A. M. Lowman, Mucosal insulin delivery systems based on complexation polymer hydrogels: effect of particle size on insulin enteral absorption, J. Control. Release, 97 115-124 (2004).